Imperial College London

DrMargaritaDominguez-Villar

Faculty of MedicineDepartment of Infectious Disease

Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 7594 3735m.dominguez-villar Website

 
 
//

Location

 

117Wright Fleming WingSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Selck:2021:10.3389/fimmu.2021.661875,
author = {Selck, C and Dominguez-Villar, M},
doi = {10.3389/fimmu.2021.661875},
journal = {Frontiers in Immunology},
title = {Antigen-specific regulatory t cell therapy in autoimmune diseases and transplantation},
url = {http://dx.doi.org/10.3389/fimmu.2021.661875},
volume = {12},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Regulatory T (Treg) cells are a heterogenous population of immunosuppressive T cells whose therapeutic potential for the treatment of autoimmune diseases and graft rejection is currently being explored. While clinical trial results thus far support the safety and efficacy of adoptive therapies using polyclonal Treg cells, some studies suggest that antigen-specific Treg cells are more potent in regulating and improving immune tolerance in a disease-specific manner. Hence, several approaches to generate and/or expand antigen-specific Treg cells in vitro or in vivo are currently under investigation. However, antigen-specific Treg cell therapies face additional challenges that require further consideration, including the identification of disease-relevant antigens as well as the in vivo stability and migratory behavior of Treg cells following transfer. In this review, we discuss these approaches and the potential limitations and describe prospective strategies to enhance the efficacy of antigen-specific Treg cell treatments in autoimmunity and transplantation.
AU - Selck,C
AU - Dominguez-Villar,M
DO - 10.3389/fimmu.2021.661875
PY - 2021///
SN - 1664-3224
TI - Antigen-specific regulatory t cell therapy in autoimmune diseases and transplantation
T2 - Frontiers in Immunology
UR - http://dx.doi.org/10.3389/fimmu.2021.661875
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000655486800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://frontiersin.org/articles/10.3389/fimmu.2021.661875/full
UR - http://hdl.handle.net/10044/1/97585
VL - 12
ER -